rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Cohu, Inc.

COHU · Nasdaq

Health CareLife-science toolsJust dropped outAI

COHU stood above a rising 150-day average in 51 of the last 52 weekly readings, and has been out of that trend for the last 1 week. It is 1.3% below that average now. Life Science Tools & Research Services: 52% of its 79 stocks in an uptrend (+4 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Just dropped out
Weeks in an uptrend
out for 1
Industry in uptrend
52% +4 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$24.4M
Officials’ trades on record
1
Institutions holding
325 (+84)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 51 of 52 weeks.

17 Apr – 16 Oct
26%41%57%Apr 26Jun 26Jul 26Sep 26Oct 26

Life-science tools: About half its stocks are in an uptrend and the share has been climbing. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$9.9M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

1 disclosed lines: House 0, Senate 0, executive 1; 1 people.

WhoDidAmountTraded
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$15k–$50k15 May 2026filed 1 Jul 2026

Insiders

Buy orders, 12 months0
Sale orders, 12 months21
Buyers · sellers0 · 8
WhoDidSharesTraded
Christopher BohrsonChief Recurring Officersold1,000at $55.3115 Oct 2026filed 16 Oct 2026
Luis A. MullerPresident & CEOsold21,662at $73.002 Oct 2026filed 5 Oct 2026
Luis A. MullerPresident & CEOsold27,236at $65.0025 Sep 2026filed 25 Sep 2026
Luis A. MullerPresident & CEOsold55,794at $60.0021 Sep 2026filed 21 Sep 2026
Christopher BohrsonSr VP & Chief Customer Officersold10,000at $55.8219 Aug 2026filed 21 Aug 2026
Christopher BohrsonSr VP & Chief Customer Officersold1,000at $61.9017 Aug 2026filed 18 Aug 2026
Andrew M. CaggiaDirectorsold10,000at $51.745 Aug 2026filed 6 Aug 2026
Andrew M. CaggiaDirectorsold5,252at $51.735 Aug 2026filed 6 Aug 2026
Nina RichardsonDirectorsold3,055at $51.545 Aug 2026filed 6 Aug 2026
Christopher BohrsonSr VP & Chief Customer Officersold1,000at $57.9215 Jul 2026filed 16 Jul 2026
Christopher BohrsonSr VP & Chief Customer Officersold1,000at $63.8815 Jun 2026filed 16 Jun 2026
James A. DonahueDirectorsold10,257at $46.7722 May 2026filed 26 May 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders325+84 on the quarter
New · exited110 · 26
Reported value$3.8B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 20267,386,449$545.9M+75,163+1.0%
Capital World Investorsnew · filed 12 Aug 20262,757,413$203.8M+2,757,413
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 20262,303,291$170.2M+264,814+13.0%
Invesco Ltd.added · filed 14 Aug 20262,030,920$150.1M+1,781,263+713.5%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20262,007,337$148.4M+39,662+2.0%
STATE STREET CORPadded · filed 7 Aug 20261,888,948$139.6M+62,612+3.4%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 20261,299,373$96.1M+122,247+10.4%
SYSTEMATIC FINANCIAL MANAGEMENT LPreduced · filed 14 Aug 20261,174,165$86.8M-227,069−16.2%
TWO SIGMA INVESTMENTS, LPadded · filed 14 Aug 20261,142,216$84.4M+47,785+4.4%
DIMENSIONAL FUND ADVISORS LPreduced · filed 11 Aug 20261,122,112$82.9M-445,399−28.4%
31 Mar 2023 – 30 Jun 2026
176248319Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Christopher Bohrson Company insiderChief Recurring Officer · last 15 Oct 20260 · 30
Luis A. Muller Company insiderPresident & CEO · last 2 Oct 20261 · 14
Andrew M. Caggia Company insiderDirector · last 25 Sep 20260 · 5
Nina Richardson Company insiderDirector · last 5 Aug 20260 · 4
Jeffrey D. Jones Company insiderSr. VP Finance & CFO · last 15 Jul 20262 · 12
James A. Donahue Company insiderDirector · last 22 May 20260 · 22
Steven J. Bilodeau Company insiderDirector · last 20 May 20260 · 15
Andreas W. Mattes Company insiderDirector · last 15 May 20260 · 0
Donald J. Trump Executive branchWhite House Office · last 15 May 20260 · 1
Karen Marie Rapp Company insiderDirector · last 15 May 20260 · 0
William Bendush Company insiderDirector · last 15 May 20260 · 15
Yon Jorden Company insiderDirector · last 15 May 20261 · 0

Same industry

OABI OmniAbLeading+65%
TXG 10x GenomicsLeading+60%
AVTR AvantorLeading+47%
ILMN IlluminaLeading+44%
RVTY RevvityLeading+37%
MASS 908 DevicesLeading+31%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Operating profit marginFY 2025 · to 27 Dec 2025-15.4%
Free cash flow marginFY 2025 · to 27 Dec 20252.4%
Return on capital employedFY 2025 · to 27 Dec 2025-6.2%
Debt to equityFY 2025 · to 27 Dec 20250.40×
Interest coverFY 2025 · to 27 Dec 2025-33.97×
Research spendFY 2025 · to 27 Dec 202520.4%
Share count trendFY 2025 · to 4 Feb 2026-6.0%
Cash and equivalentsFY 2025 · to 27 Dec 2025$227.1M
Free cash flowFY 2025 · to 27 Dec 2025$10.7M

Analyst forecasts

No analyst forecasts yet.